WINNIPEG, MB, July 30, 2021
/CNW/ - Medicure Inc. ("Medicure" or the "Company")
(TSXV: MPH) (OTC: MCUJF), a company focused on the development and
commercialization of pharmaceuticals and healthcare products for
patients and prescribers in the United
States market, announced today that it has granted
stock options (the "Options") to certain officers of the Company to
purchase a total of 90,000 common shares at a price of $1.10 per common share. The Options, which vest
immediately, are exercisable for a period of five years and have
been granted in accordance with the terms of the Company's current
stock option plan. The grant of Options is subject to the
approval of the TSX Venture Exchange.
About Medicure Inc.
Medicure is a pharmaceutical
company focused on the development and commercialization of
therapies for the U.S. cardiovascular market. The present focus of
the Company is the marketing and distribution of
AGGRASTAT® (tirofiban hydrochloride) injection and
ZYPITAMAG® (pitavastatin) tablets in the United States, where they are sold through
the Company's U.S. subsidiary, Medicure Pharma Inc. Medicure also
operates Marley Drug, Inc. ("Marley"), a pharmacy located in
North Carolina that offers an
Extended Supply mail order drug program serving 49 states,
Washington D.C. and Puerto Rico. Marley is committed to improving
the health status of its patients and the communities they serve
while reducing overall health care costs for employers and other
health care consumers. For more information visit
www.marleydrug.com. To learn more about The Extended Supply Generic
Drug Program call 800.286.6781 or email
info@marleydrug.com. For more information on Medicure please
visit www.medicure.com. For additional information about
AGGRASTAT®, refer to the full Prescribing Information.
For additional information about ZYPITAMAG®, refer to
the full Prescribing Information.
To be added to Medicure's e-mail list, please
visit:
http://medicure.mediaroom.com/alerts
View original
content:https://www.prnewswire.com/news-releases/medicure-announces-grant-of-stock-options-301344839.html
SOURCE Medicure Inc.